Am J Hematol

1. STUVER R, Mian A, Brown S, Devlin S, et al
   BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
   Am J Hematol. 2024 Mar 25. doi: 10.1002/ajh.27291.
   

   >> Share

   
   

   
   Blood

2. GROVER NS, Beaven AW
   T-cell lymphoma: the CAR-T revolution is coming.
   Blood. 2024;143:1201-1202.
   

   >> Share

   
   
3. GIESSINGER J, Pullarkat ST
   An unusual presentation of lymphoplasmacytic lymphoma with isolated brachial plexus infiltration and amyloidosis.
   Blood. 2024;143:1315.
   

   >> Share

   
   
4. 
   Zinzani PL, Thieblemont C, Melnichenko V, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. Blood. 2023;142(2):141-145.
   Blood. 2024;143:1316.
   

   >> Share

   
   
5. HILL LC, Rouce RH, Wu MJ, Wang T, et al
   Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
   Blood. 2024;143:1231-1241.
   

   >> Share

   
   

   
   BMC Cancer

6. MCILROY G, Lax S, Gaskell C, Jackson A, et al
   Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
   BMC Cancer. 2024;24:370.
   

   >> Share

   
   

   
   Br J Haematol

7. MERLI M, Costantini A, Tafuri S, Bavaro DF, et al
   Management of vaccinations in patients with non-Hodgkin lymphoma.
   Br J Haematol. 2024 Mar 26. doi: 10.1111/bjh.19422.
   

   >> Share

   
   

   
   Haematologica

8. BI C, Huang Y, Ali R, Wang F, et al
   MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
   Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2023.283811.
   

   >> Share

   
   
9. PULCZYNSKI EJ, Simonsen MR, Kuittinen O, Fagerli UM, et al
   Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
   Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2024.285207.
   

   >> Share

   
   

   
   J Clin Oncol

10. BINKLEY MS, Flerlage JE, Savage KJ, Akhtar S, et al
    International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    J Clin Oncol. 2024 Mar 26:JCO2301655. doi: 10.1200/JCO.23.01655.
    

    >> Share

    
    
11. MEHTA-SHAH N, Horwitz SM
    Failing Forward in Peripheral T-Cell Lymphoma.
    J Clin Oncol. 2024 Mar 26:JCO2302658. doi: 10.1200/JCO.23.02658.
    

    >> Share

    
    

    
    Leukemia

12. OERTEL M, Ziepert M, Frontzek F, Nacke N, et al
    Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial.
    Leukemia. 2024 Mar 27. doi: 10.1038/s41375-024-02231.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share